Advertisement

Topics

Evolocumab doesn't affect cognition when added to statins

09:40 EDT 17 Aug 2017 | Medical Xpress

(HealthDay)—There is no significant difference in cognitive function for patients treated with evolocumab or placebo added to statin therapy, according to a study published in the Aug. 17 issue of the New England Journal of Medicine.

Original Article: Evolocumab doesn't affect cognition when added to statins

NEXT ARTICLE

More From BioPortfolio on "Evolocumab doesn't affect cognition when added to statins"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Statins
Statins (or HMG-CoA reductase inhibitors) are a class of drug used to lower cholesterol levels by inhibiting the enzyme HMG-CoA reductase, which plays a central role in the production of cholesterol in the liver. Increased cholesterol levels have been as...